{
    "title": "Fenbendazole vs Cancer",
    "inventor_name": null,
    "publication_year": null,
    "device_name": "Fenbendazole",
    "goal": "Use the anti-worm drug fenbendazole as an anti-cancer therapy",
    "problem_addressed": "Various cancers, especially small-cell lung cancer and metastatic tumors",
    "concept_summary": "Fenbendazole, a benzimidazole anti-worm medication, is reported to have anti-cancer activity by destabilising microtubules, inhibiting glucose uptake, blocking proteasome function and inducing apoptosis. Anecdotal human case reports and in-vitro studies suggest tumour regression and long-term remission, though no controlled clinical trials exist.",
    "detailed_description": "The article describes the case of Joe Tippens, a patient with late-stage small-cell lung cancer who, after being given a prognosis of three months, took fenbendazole (a veterinary de-wormer) alongside vitamin E, CBD and curcumin. Within weeks his PET scans showed no detectable cancer, and he remained cancer-free for at least two years. The text also cites a Nature paper reporting that fenbendazole acts as a moderate microtubule-destabilising agent, blocks GLUT4-mediated glucose uptake, interferes with the proteasome, and triggers apoptotic pathways in cancer cells. Additional anecdotal reports of remission in pancreatic, prostate, colorectal, melanoma and glioblastoma are mentioned. The drug is inexpensive, widely available as Panacur/Safe-Guard, and is considered to have low toxicity compared with conventional chemotherapy, but no formal clinical trials have been conducted.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Microtubule destabilisation",
        "Proteasome inhibition",
        "Glucose uptake blockade",
        "Induction of apoptosis",
        "Metabolic starvation of cancer cells"
    ],
    "scientific_domains": [
        "Pharmacology",
        "Oncology",
        "Cell Biology",
        "Molecular Biology"
    ],
    "mechanisms_of_action": [
        "Microtubule destabilisation",
        "Proteasome inhibition",
        "Inhibition of GLUT4 glucose transporter expression",
        "Induction of G2/M cell-cycle arrest and apoptosis"
    ],
    "materials": [
        "Fenbendazole (benzimidazole compound)",
        "Panacur (commercial formulation)",
        "Safe-Guard (commercial formulation)"
    ],
    "energy_sources": [],
    "inputs": [
        "Oral fenbendazole (dog de-wormer pills)",
        "Vitamin E",
        "CBD oil",
        "Bioavailable curcumin"
    ],
    "outputs": [
        "Cancer cell death",
        "Tumour shrinkage",
        "Complete remission in reported cases"
    ],
    "claimed_performance": "Complete disappearance of detectable cancer within weeks to months; long-term cancer-free status maintained for years in anecdotal reports.",
    "experimental_evidence": "Anecdotal human case (Joe Tippens) with PET scans showing no cancer after fenbendazole treatment; in-vitro studies and a Nature paper demonstrating microtubule destabilisation and cancer-cell death; additional anecdotal reports of remission in several cancer types.",
    "replication_status": "No independent clinical replication reported; only isolated case reports and pre-clinical studies.",
    "keywords": [
        "Fenbendazole",
        "anti-worm",
        "cancer",
        "microtubule",
        "chemotherapy",
        "case report",
        "small cell lung cancer"
    ],
    "related_technologies": [
        "Mebendazole",
        "Taxol (paclitaxel)",
        "Vinca alkaloids",
        "Benzimidazoles"
    ],
    "controversy_level": "high",
    "confidence_score": 0.6,
    "practicability_score": 0.7,
    "fringe_score": 0.8,
    "evidence_strength": 0.4,
    "risk_score": 0.5,
    "trl_estimate": 3,
    "source_urls": [
        "https://www.dailymail.co.uk/health/article-6965325/Oklahoma-grandfather-claims-drug-DOGS-cured-cancer-tumor-free.html",
        "https://www.koco.com/article/edmond-man-claims-cheap-drug-for-dogs-cured-his-cancer/27276538",
        "https://www.cancertreatmentsresearch.com/the-over-the-counter-drug-mebendazole-acts-like-chemotherapy-but-with-virtually-no-side-effects/",
        "https://www.cancertreatmentsresearch.com/fenbendazole/",
        "https://www.curezone.org/forums/am.asp?i=2104704"
    ],
    "organizations": [
        "MD Anderson Cancer Center",
        "Oklahoma Medical Research Foundation",
        "KOCO News",
        "CureZone"
    ],
    "applications": [
        "Adjunct cancer therapy",
        "Potential standalone anti-cancer agent"
    ],
    "limitations": [
        "No peer-reviewed clinical trials",
        "Reliance on anecdotal evidence",
        "Unclear optimal dosing and pharmacokinetics in humans",
        "Potential drug-interaction risks"
    ],
    "open_questions": [
        "What is the effective therapeutic dose in humans?",
        "Does fenbendazole improve outcomes when combined with standard chemotherapy?",
        "What are the long-term safety profiles for human use?",
        "Is the anti-cancer effect reproducible across diverse cancer types?"
    ],
    "red_flags": [
        "Self-medication without medical supervision",
        "Lack of regulatory approval for cancer treatment",
        "Potential for misinformation and scams"
    ],
    "evidence_quotes": [
        "By May 2017, all cancer had disappeared from Joe's scans.",
        "The paper, entitled 'Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways', concludes that fenbendazole displays anti-neoplastic activity.",
        "Fenbendazole inhibits the cellular proteasome function dose- and time-dependently and leads to accumulation of ubiquitylated derivatives of various cellular proteins, including p53, which, in turn, leads to apoptosis via the mitochondrial pathway.",
        "A veterinarian suggested he try the dog de-worming drug, fenbendazole, which has shown cancer-fighting properties in cell studies.",
        "Joe's doctor told him, 'We don't quite know what to make of this as you are the only patient on the clinical trial with this kind of response.'"
    ]
}